Agappe launches new clinical analyzer in India

Kochi, May 17 (UNI) Agappe Diagnostics Ltd. today announced the launch of a Japanese-made compact fully automatic clinical analyzer called 'Biolis 12i' in the Indian market.

Addressing a press conference here, Agappe Managing Director Thomas John said that the equipment was the first of its kind and had been launched only in the US and Europe so far.

The approximate cost of the machine, manufactured by Tokyo Boeki Machinery Ltd., would be about Rs ten lakh.

Tokyo Boeki Marketing In-Charge, South East Asia, Kanetsuki Toshaiki said the equipment was originally planned to be launched only in the western markets.

Its introduction in India was a clear indication of the Japanese company's growing relations with Agappe and its commitment to the Indian customers, he said.

Agappe also announced the launch of 'Cystatin C', a sensitive alternative to estimate glomurular filtration rate. Being launched in technical collaboration with Denka Seiken Co. of Japan, 'Cystatin c' was a superior marker for early identification of chronic kidney disease, Mr John said.

'Kidscreen', a complete solution for reanalysis, was also launched.

Mr John said his company, which launched operations 15 years ago, was aiming for a turnover of about Rs 40 crore during 2008-09, which would be a 300 per cent increase over the turnover for the previous year.

Agappe, which specialised in manufacturing reagents and biochemistry diagnostic kits, exported almost ten per cent of its volume. It was planning to set up a subsidiary in Dubai.

The company was also planning to enter the lab and food chemicals business by next year and had already acquired 65 cents of land from KINFRA to set up a medium-scale enterprise.

UNI ARC KKS1500